If I Purchase a Full-Body Screening, Can I Write It Off as a Medical Expense?

Understanding How Tax Eligibility Works

Many patients do use their Life Imaging receipt when filing taxes, but whether it qualifies as a deductible medical expense depends entirely on your personal circumstances. A full-body screening is considered preventive imaging, and the IRS evaluates deductions based on how the service fits into your overall medical needs not everyone will qualify in the same way.

Why It’s Different for Every Patient

Some individuals are able to claim the scan because it falls under doctor-guided medical spending. Others may not qualify if the scan was purchased strictly for personal wellness or early detection without a physician’s referral. The IRS typically draws a line between medically necessary procedures and elective preventive care, and that distinction affects how the expense is treated at tax time.

Keeping your receipt is important because it provides the documentation your tax advisor needs to determine whether the screening meets the eligibility criteria in your case.

What You Should Do Before Filing

If you’re hoping to write off the screening, the best next step is to speak directly with a qualified tax professional. They can review your medical spending for the year, consider whether the scan fits IRS guidelines, and let you know what is and isn’t likely to qualify. Life Imaging cannot determine tax eligibility, but they do provide patients with a clear receipt and service summary that your preparer may request.

A Helpful Closing Thought

Your full-body scan may qualify as a deductible medical expense, but it truly depends on your personal tax situation, documentation, and IRS rules. Keeping your paperwork and checking with your tax advisor is the best way to know exactly how the expense applies in your case.

What Does Pfizer Say About Preventive Screening?

According to Pfizer, understanding the pros and cons of cancer screening is essential because early detection can help identify health issues at more treatable stages. Their guidance emphasizes that screening decisions should be informed, personal, and based on a clear understanding of potential benefits, particularly the advantage of catching abnormalities before symptoms appear.

For more details, visit Pfizer:
https://www.pfizer.com/news/articles/cancer_screenings_understanding_the_pros_and_cons